Olivier Brandicourt Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

Olivier Brandicourt is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 775 shares of ALNY, which is worth approximately $226,191. The most recent transaction as insider was on May 08, 2025, when has been sold 775 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 775

n/a 3M change

n/a 12M change

Total Value Held $226,191

OLIVIER BRANDICOURT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 08 2025	BUY Grant, award, or other acquisition	-	775 Added 50.0%	775 Common Stock

Also insider at

BGNE

BeiGene, Ltd. Healthcare

Director

PCVX

Vaxcyte, Inc. Healthcare

Director